Tryptophan malabsorption in levodopa-treated parkinsonian patients. Effect of tryptophan on mental disturbances (Q48694166)

14 February 2018

title

Tryptophan malabsorption in levodopa-treated parkinsonian patients. Effect of tryptophan on mental disturbances (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4746526

28 February 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

28 February 2023

author name string

J. Lehmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4746526

28 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4746526

28 February 2023

publication date

1 January 1973

1 reference

14 February 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.0954-6820.1973.tb19428.x

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0954-6820.1973.tb19428.x/fullpdf

28 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

28 February 2023

published in

Acta medica Scandinavica

1 reference

14 February 2018

volume

194

1 reference

14 February 2018

issue

3

1 reference

14 February 2018

page(s)

181-189

1 reference

14 February 2018

Oral L-dopa treatment of parkinsonism.

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.

28 February 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

28 February 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Behavioral and biochemical effects ofl-DOPA after peripheral decarboxylase inhibition

28 February 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.

28 February 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism

28 February 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Inhibition of L-Phenylalanine Absorption by L-DOPA in Patients with Parkinsonism

28 February 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

On the Occurrence of Homovanillic Acid and 5-Hydroxyindol-3-ylacetic Acid in the Ventricular C.S.F. of Patients Suffering from Parkinsonism

28 February 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

A RELATIONSHIP BETWEEN BLOOD SEROTONIN CONCENTRATIONS AND BEHAVIOR IN PSYCHIATRIC PATIENTS.

28 February 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Further studies on tryptophan hydroxylase in rat brainstem and beef pineal

28 February 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.

28 February 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L-DOPA

28 February 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

MENTAL DISTRUBANCES FOLLOWED BY STUPOR IN A PATIENT WITH CARCINOIDOSIS: Recovery with Tryptophan treatment

28 February 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

An Improved Fluorometric Method for the Determination of Tryptophan in Urine Using Sephadex G-10 Extraction

28 February 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

28 February 2023

Q64969730

26

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Transport of l-tyrosine by the small intestine in vitro

28 February 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Occurrence and distribution of L-DOPA decarboxylase in the human brain.

28 February 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

DISORDERS OF AMINO-ACID TRANSPORT

28 February 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Interaction in the cerebral metabolism of the biogenic amines: Effect of intravenous infusion of l‐tryptophan on the metabolism of dopamine and 5‐hydroxyindoles in brain and cerebrospinal fluid

28 February 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain

28 February 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

INHIBITION BY PHENYLALANINE OF THE ENTRY OF 5-HYDROXY-TRYPTOPHAN-1-C14 INTO CEREBROSPINAL FLUID.

28 February 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Studies on the uptake of radiolabeled DOPA, 5-HTP and tryptophan in rat tissues in vivo: effect of methionine, tryptophan and some keto acids.

28 February 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

Phenylalanine and tyrosine metabolism in Parkinson's disease treated with levodopa

28 February 2023

38

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

The effect of L-Dopa on monoamine metabolites in Parkinson's disease

28 February 2023

40

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1973.TB19428.X

28 February 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4746526

28 February 2023

1 reference

14 February 2018